Medarex Inc. (Nasdaq: MEDX) indicated that its prostate cancer treatment showed promise sending the stock price up $1.17 to $8.53.
Medarex's Cancer Treatment Shows Promise
June 22, 2009 at 13:52 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.